$13.86
In stock
Guaranteed refund or reship if you haven't received your order
Secure and encrypted payment processing
We ship to over 40 countries including the USA, UK, Europe, Australia and Japan

Pharmacological properties

When using the drug for therapeutic purposes, it reduces chills and normalizes body temperature; reduces inflammation of the upper respiratory tract, runny nose and cough; headache and weakness, reduces the severity of pain in muscles and joints; activates the bodys defenses; accelerates recovery, prevents the development of complications.

When used prophylactically, the drug strengthens the bodys overall resistance; increases local immunity of the upper respiratory tract; reduces the likelihood of getting the flu and the common cold.

The drug stimulates the synthesis of interferon and the cellular component of immunity, which allows it to be used at different stages of the infectious process (both for prevention and treatment). It has an anti-inflammatory effect on the mucous membranes and synovial membranes, which leads to a decrease in the severity of exudation and edema. It has a detoxifying and mild antipyretic effect. The double mechanism of action is provided both by improving the systemic and local immunity of the body, and by the direct antiviral effect of the drug.

Indications

Prevention and treatment of influenza and the common cold (ARVI), in the complex treatment of inflammatory and rheumatic diseases with joint pain.

Application

Drop-shaped aflubins for oral administration

Aflubin for treatment
1-2 day of a cold or flu
Adults and children over 12 years old 10 drops 3-8 times a day.

To quickly improve the condition, take the drug every 0.5–1 hours, but no more than 8 times a day

Children 5-12 years old 5–9 drops
Children 2–4 years old 2–4 drops
3rd – 7th day of illness (or until recovery)
Adults and children over 12 years old 10 drops 3 times a day
Children aged 5–12 years 5 drops 3 times a day
Children aged 2–4 years 2–4 drops 3 times a day
Aflubin for prevention
Routine prophylaxis should be started 1 month before the seasonal increase in the incidence of respiratory viral infections or during the outbreak
Adults and children over 12 years old 10 drops 2 times a day, 3 weeks
Children aged 2–12 years 2–9 drops 2 times a day, 3 weeks
Emergency prophylaxis in contact with a patient with influenza / SARS or under the influence of provoking factors (hypothermia, sudden climate change)
Adults and children over 12 years old 10 drops 2 times a day, 2-3 days
Children aged 2–12 years 2–9 drops 2 times a day, 2-3 days

Aflubin in the form of tablets

Start treatment

A patient Dosage A course of treatment

Tags: Aflubin